CDKN2A rs3731204: Understanding Genetic Associations with CLL
The rs3731204 variant is a specific genetic change located within the CDKN2A gene region. Research has identified this variant as having a statistical association with the risk of developing chronic lymphocytic leukemia (CLL) and its potential influence on immune response pathways.
What each genotype means
Baseline risk profile
This genotype represents the baseline state for this variant. Research indicates that this specific genetic marker is associated with variations in chronic lymphocytic leukemia risk, though individual risk is influenced by many factors beyond a single genetic variant.
This genotype is common in many global populations, though exact frequencies vary significantly by ancestry.
Altered immune response profile
Carriers of this genotype show evidence of altered CDKN2A gene expression and changes in specific immune cell subsets. While this variant is statistically linked to chronic lymphocytic leukemia risk, it does not determine a clinical diagnosis or influence treatment timing.
This heterozygous genotype is found at varying frequencies across diverse populations, reflecting the common nature of this variant.
Increased risk association
This genotype has been identified in large-scale studies as having a significant statistical association with an increased risk of chronic lymphocytic leukemia. It is linked to changes in immune response pathways and gene expression, but it is not a diagnostic indicator of disease.
This genotype is observed in a subset of the population, with prevalence rates that differ depending on ancestral background.
What is the rs3731204 Variant?
The rs3731204 variant is a single nucleotide polymorphism (SNP) located in the genomic region of the CDKN2A gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated on chromosome 9, a region frequently studied for its role in cell cycle regulation and cancer predisposition. Scientists identify such variants through genome-wide association studies (GWAS), which compare the DNA of individuals with a specific condition to those without it to find statistical correlations. It is important to note that the presence of a specific SNP does not mean an individual will develop a disease; rather, it indicates a small change in the genetic code that has been statistically linked to a trait or condition in large population studies.
The Role of the CDKN2A Gene
The CDKN2A gene is a critical tumor suppressor gene that plays a fundamental role in controlling the cell cycle. It provides instructions for making proteins that act as 'brakes' on cell division, preventing cells from growing and dividing too rapidly or in an uncontrolled way. Because of this function, the gene is essential for maintaining cellular health and preventing the formation of tumors. When the function of CDKN2A is impaired—whether through somatic mutations acquired during a person's lifetime or through inherited variations—the body's ability to regulate cell proliferation can be compromised. This gene is widely recognized in oncology as one of the most frequently inactivated genes in various human cancers, highlighting its importance in maintaining genomic stability and preventing malignancy.
Research and Evidence Strength
The association between rs3731204 and chronic lymphocytic leukemia (CLL) is supported by moderate evidence derived from genetic association studies. Researchers have investigated this variant to understand how it might influence the immune system and the development of lymphoid malignancies. Studies, such as those published in Nature Genetics, have identified susceptibility loci in the CDKN2A region that contribute to the inherited risk of CLL. While these findings provide valuable insights into the biological pathways involved in leukemia, the evidence is considered moderate because genetic risk is often complex and influenced by many different factors, including other genes and environmental exposures. It is essential to interpret these findings as statistical associations rather than direct causes of disease, as the biological mechanisms linking this specific SNP to CLL are still being actively researched.
Population Frequency and Variability
The frequency of the rs3731204 variant is known to be variable across different human populations. Genetic variants often show different distribution patterns depending on ancestral background, which is a common observation in large-scale genomic databases like gnomAD. Because allele frequencies can differ significantly between groups, the statistical impact of a variant on disease risk may also vary depending on the population being studied. Researchers use these frequency data to better understand the evolutionary history of genetic markers and to refine risk models. If you are interested in how this variant appears in specific ancestral groups, public databases provide aggregated data that reflect these global differences. Understanding this variability is a key component of modern genomics, as it helps scientists account for diversity when studying the genetic architecture of complex diseases.
What This Information Means for You
Learning about a genetic variant like rs3731204 can be an educational experience, but it is important to maintain a clear perspective on what this information means for your health. A statistical association with a disease risk does not constitute a medical diagnosis. Many factors, including lifestyle, environment, and the interaction of thousands of other genes, contribute to overall health outcomes. You cannot use this information to predict your personal risk of developing CLL or to make medical decisions. If you have concerns about your family history or personal health, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your full medical history and guide you on appropriate screenings or preventative measures, ensuring that any health decisions are based on comprehensive clinical evidence.
How common is this variant?
The frequency of the rs3731204 variant is variable across different global populations, with specific allele distributions documented in large-scale genomic databases.
Frequently asked questions
Does having the rs3731204 variant mean I will get leukemia?
No, having this variant does not mean you will develop leukemia. It is a statistical marker associated with a slightly altered risk in population studies, not a diagnostic test for disease.
What is the function of the CDKN2A gene?
The CDKN2A gene acts as a tumor suppressor by producing proteins that regulate the cell cycle. It helps prevent cells from dividing uncontrollably, which is a key defense against cancer.
Where can I find more information about my own genetic risk?
If you are concerned about your genetic risk for any condition, you should speak with a doctor or a certified genetic counselor. They can interpret your family history and clinical data in a way that is relevant to your personal health.
Is rs3731204 the only factor in CLL risk?
No, CLL risk is complex and influenced by many genetic and environmental factors. This variant is only one of many potential contributors identified by researchers.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3731204?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2A
Variant upstream of CDKN2A/B associated with type 2 diabetes susceptibility.
Non-coding regulatory variant in the 9p21.3 tumor suppressor locus associated with susceptibility to cutaneous melanoma and common vascular phenotypes.
This variant is associated with an increased risk of type 2 diabetes in various populations.